Vesper Energy to Supply Solar Power to Pfizer’s North American Operations

Oct. 28, 2021
Vesper’s 500 MW Hornet Solar project will provide 310 MW of clean energy

Pfizer has signed a 15-year virtual power purchase agreement with renewable energy assets firm Vesper Energy to supply at least 310 MW of clean solar energy to the grid. The energy supplied will cover the projected power requirement of the biopharmaceutical firm’s North American operations.

The solar power will come from Vesper’s 500 MW Hornet Solar project in west Texas.

“At Pfizer, we apply science to the world’s greatest health challenges, and that commitment extends to confronting climate change, which has profound societal and public health impacts,” said Bill Carapezzi, Executive Vice President, Global Business Services and Transformation at Pfizer. “We are delighted to enter into this virtual power purchase agreement, which is a significant step toward reaching our 2030 goal to purchase 100% renewable energy.”

Vesper Energy CEO Craig Carson said, “We are proud to partner with Pfizer as it takes a major step in reducing the carbon footprint of its North American operations and reaching carbon neutrality. Vesper’s Hornet Solar project is a strong example of how we put high-quality renewable infrastructure to work to solve our customers’ energy challenges, while making meaningful contributions to the greater sustainability movement.”

Vesper’s 500MW Hornet Solar project will be fully operational by the end of 2023.